217 related articles for article (PubMed ID: 28359267)
1. Aberrant expression of ALK and EZH2 in Merkel cell carcinoma.
Veija T; Koljonen V; Bohling T; Kero M; Knuutila S; Sarhadi VK
BMC Cancer; 2017 Mar; 17(1):236. PubMed ID: 28359267
[TBL] [Abstract][Full Text] [Related]
2. ALK and EGFR expression by immunohistochemistry are associated with Merkel cell polyomavirus status in Merkel cell carcinoma.
Veija T; Kero M; Koljonen V; Böhling T
Histopathology; 2019 May; 74(6):829-835. PubMed ID: 30588655
[TBL] [Abstract][Full Text] [Related]
3. Hotspot mutations in polyomavirus positive and negative Merkel cell carcinomas.
Veija T; Sarhadi VK; Koljonen V; Bohling T; Knuutila S
Cancer Genet; 2016; 209(1-2):30-5. PubMed ID: 26725423
[TBL] [Abstract][Full Text] [Related]
4. Distinct Regulation of EZH2 and its Repressive H3K27me3 Mark in Polyomavirus-Positive and -Negative Merkel Cell Carcinoma.
Durand MA; Drouin A; Mouchard A; Durand L; Esnault C; Berthon P; Tallet A; Le Corre Y; Hainaut-Wierzbicka E; Blom A; Saiag P; Beneton N; Bens G; Nardin C; Aubin F; Dinulescu M; Collin C; Fromont-Hankard G; Cribier B; Laurent-Roussel S; Cokelaere K; Houben R; Schrama D; Peixoto P; Hervouet E; Bachiri K; Kantar D; Coyaud E; Guyétant S; Samimi M; Touzé A; Kervarrec T
J Invest Dermatol; 2023 Oct; 143(10):1937-1946.e7. PubMed ID: 37037414
[TBL] [Abstract][Full Text] [Related]
5. UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell Carcinomas.
Wong SQ; Waldeck K; Vergara IA; Schröder J; Madore J; Wilmott JS; Colebatch AJ; De Paoli-Iseppi R; Li J; Lupat R; Semple T; Arnau GM; Fellowes A; Leonard JH; Hruby G; Mann GJ; Thompson JF; Cullinane C; Johnston M; Shackleton M; Sandhu S; Bowtell DD; Johnstone RW; Fox SB; McArthur GA; Papenfuss AT; Scolyer RA; Gill AJ; Hicks RJ; Tothill RW
Cancer Res; 2015 Dec; 75(24):5228-34. PubMed ID: 26627015
[TBL] [Abstract][Full Text] [Related]
6. Molecular Profiling of Multiple Primary Merkel Cell Carcinoma to Distinguish Genetically Distinct Tumors From Clonally Related Metastases.
Harms KL; Lazo de la Vega L; Hovelson DH; Rahrig S; Cani AK; Liu CJ; Fullen DR; Wang M; Andea AA; Bichakjian CK; Johnson TM; Tomlins SA; Harms PW
JAMA Dermatol; 2017 Jun; 153(6):505-512. PubMed ID: 28403382
[TBL] [Abstract][Full Text] [Related]
7. Methyltransferase-independent function of enhancer of zeste homologue 2 maintains tumorigenicity induced by human oncogenic papillomavirus and polyomavirus.
Khattri M; Amako Y; Gibbs JR; Collura JL; Arora R; Harold A; Li MY; Harms PW; Ezhkova E; Shuda M
Tumour Virus Res; 2023 Dec; 16():200264. PubMed ID: 37244352
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and predictive value of EZH2 expression and the tumor immune microenvironment in Merkel cell carcinoma.
Acikalin A; Bagir E; Paydas S
Pol J Pathol; 2021; 72(2):140-147. PubMed ID: 34706521
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of EZH2 in Merkel cell carcinoma is associated with disease progression and poorer prognosis.
Harms KL; Chubb H; Zhao L; Fullen DR; Bichakjian CK; Johnson TM; Carskadon S; Palanisamy N; Harms PW
Hum Pathol; 2017 Sep; 67():78-84. PubMed ID: 28739498
[TBL] [Abstract][Full Text] [Related]
10. Association of expression of the hedgehog signal with Merkel cell polyomavirus infection and prognosis of Merkel cell carcinoma.
Kuromi T; Matsushita M; Iwasaki T; Nonaka D; Kuwamoto S; Nagata K; Kato M; Akizuki G; Kitamura Y; Hayashi K
Hum Pathol; 2017 Nov; 69():8-14. PubMed ID: 28551328
[TBL] [Abstract][Full Text] [Related]
11. miRNA-34a underexpressed in Merkel cell polyomavirus-negative Merkel cell carcinoma.
Veija T; Sahi H; Koljonen V; Bohling T; Knuutila S; Mosakhani N
Virchows Arch; 2015 Mar; 466(3):289-95. PubMed ID: 25491743
[TBL] [Abstract][Full Text] [Related]
12. Prospective study of Merkel cell polyomavirus and risk of Merkel cell carcinoma.
Faust H; Andersson K; Ekström J; Hortlund M; Robsahm TE; Dillner J
Int J Cancer; 2014 Feb; 134(4):844-8. PubMed ID: 23922031
[TBL] [Abstract][Full Text] [Related]
13. The Merkel cell polyomavirus and its involvement in Merkel cell carcinoma.
Amber K; McLeod MP; Nouri K
Dermatol Surg; 2013 Feb; 39(2):232-8. PubMed ID: 23387356
[TBL] [Abstract][Full Text] [Related]
14. RB1 gene in Merkel cell carcinoma: hypermethylation in all tumors and concurrent heterozygous deletions in the polyomavirus-negative subgroup.
Sahi H; Savola S; Sihto H; Koljonen V; Bohling T; Knuutila S
APMIS; 2014 Dec; 122(12):1157-66. PubMed ID: 24735260
[TBL] [Abstract][Full Text] [Related]
15. Next generation sequencing of Cytokeratin 20-negative Merkel cell carcinoma reveals ultraviolet-signature mutations and recurrent TP53 and RB1 inactivation.
Harms PW; Collie AM; Hovelson DH; Cani AK; Verhaegen ME; Patel RM; Fullen DR; Omata K; Dlugosz AA; Tomlins SA; Billings SD
Mod Pathol; 2016 Mar; 29(3):240-8. PubMed ID: 26743471
[TBL] [Abstract][Full Text] [Related]
16. Merkel cell carcinoma: histopathologic and prognostic features according to the immunohistochemical expression of Merkel cell polyomavirus large T antigen correlated with viral load.
Leroux-Kozal V; Lévêque N; Brodard V; Lesage C; Dudez O; Makeieff M; Kanagaratnam L; Diebold MD
Hum Pathol; 2015 Mar; 46(3):443-53. PubMed ID: 25623078
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of p53 restriction in Merkel cell carcinoma cells are independent of the Merkel cell polyoma virus T antigens.
Houben R; Dreher C; Angermeyer S; Borst A; Utikal J; Haferkamp S; Peitsch WK; Schrama D; Hesbacher S
J Invest Dermatol; 2013 Oct; 133(10):2453-2460. PubMed ID: 23563200
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous squamous and neuroendocrine carcinoma: genetically and immunohistochemically different from Merkel cell carcinoma.
Pulitzer MP; Brannon AR; Berger MF; Louis P; Scott SN; Jungbluth AA; Coit DG; Brownell I; Busam KJ
Mod Pathol; 2015 Aug; 28(8):1023-32. PubMed ID: 26022453
[TBL] [Abstract][Full Text] [Related]
19. Merkel Cell Carcinoma Sensitivity to EZH2 Inhibition Is Mediated by SIX1 Derepression.
Gartin AK; Frost TC; Cushman CH; Leeper BA; Gokhale PC; DeCaprio JA
J Invest Dermatol; 2022 Oct; 142(10):2783-2792.e15. PubMed ID: 35331717
[TBL] [Abstract][Full Text] [Related]
20. The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy.
Knepper TC; Montesion M; Russell JS; Sokol ES; Frampton GM; Miller VA; Albacker LA; McLeod HL; Eroglu Z; Khushalani NI; Sondak VK; Messina JL; Schell MJ; DeCaprio JA; Tsai KY; Brohl AS
Clin Cancer Res; 2019 Oct; 25(19):5961-5971. PubMed ID: 31399473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]